The 146th Annual Meeting of the Pharmaceutical Society of Japan (Osaka)
Advanced Search

Session Details

Joint Symposium

[JS03★☆]Immunotoxicity for Drug Development and Clinical Applications

Fri. Mar 27, 2026 9:30 AM - 11:30 AM JST
Fri. Mar 27, 2026 12:30 AM - 2:30 AM UTC
Room 18 (A202)
Organizer: Yoshiro Saito (Natl. Inst. Health Sci.), Masashi Tachibana (College Life Sci., Ritsumeikan Univ.)
Co-sponsored by:
The Pharmaceutical Society of Japan,
The Japanese Society of Immunotoxicology
9:30 AM - 9:50 AM JST(12:30 AM - 12:50 AM UTC)

[JS03-1]Overview of immunotoxicity in drug development and clinical setting

○Yoshiro Saito1, Masashi Tachibana2 (1. Natl. Inst. Health Sci., 2. College Life Sci., Ritsumeikan Univ.)
9:50 AM - 10:15 AM JST(12:50 AM - 1:15 AM UTC)

[JS03-2]Pharmacological and immunological mechanisms of idiosyncratic adverse drug reactions

○Shigeki Aoki1 (1. Grad. Sch. Pharm. Sci., Chiba Univ.)
10:15 AM - 10:40 AM JST(1:15 AM - 1:40 AM UTC)

[JS03-3]Study on the evaluation of innate immune activation of oligonucleotide therapeutics

○Tokuyuki Yoshida1 (1. Natl. Inst. Health Sci.)
10:40 AM - 11:05 AM JST(1:40 AM - 2:05 AM UTC)

[JS03-4]Current status and future of immunotoxicity and immunogenicity assessment for biopharmaceuticals

○Chiyomi Kubo1 (1. Chugai Pharmaceutical Co., Ltd. TR Division)
11:05 AM - 11:30 AM JST(2:05 AM - 2:30 AM UTC)

[JS03-5]Discussion and proposals from the Japanese Society of Immunotoxicology toward the revision of ICH S8 guideline

○Tetsuya Sakairi1 (1. Tanabe Pharma Corp.)
Back to Category List